Skip to content

Cardiac Rehabilitation and Low Frequency Electrical MyoStimulation in Chronic Heart Failure

Cardiac Rehabilitation and Low Frequency Electrical MyoStimulation in Chronic Heart Failure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01408875
Acronym
CREMS-HF
Enrollment
94
Registered
2011-08-03
Start date
2011-10-31
Completion date
2014-01-31
Last updated
2015-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Keywords

Chronic Heart Failure, Cardiac rehabilitation, Exercise training, Peak VO2, Electrical myostimulation

Brief summary

The purpose of this study is to determine if addition of low frequency electro-myo-stimulation to cardiac rehabilitation is effective to improve exercise capacity and/or muscular strength in chronic heart failure patients.

Detailed description

In chronic heart failure, low exercise capacity is due, in part, to peripheral muscles abnormalities. Exercise training performed during cardiac rehabilitation improves exercise tolerance measured by cardiopulmonary exercise test. Low frequency electromyostimulation (EMS) was proposed as an alternative to exercise training (ET) in this population. However, the effectiveness of the combination (EMS +ET) compared with ET alone is not proved. The main objective is to compare exercise capacity judged by peak VO2 after treatment by ET alone versus EMS+ET. The secondary end points are results on sub maximal parameters, muscular resistance, quality of life and effectiveness regarding clinical sub-groups. This study is a controlled, randomized, multicentric (14 centres) designed to include 90 patients by group in two years period. Inclusion criteria are: CHF patients , NYHA class II to IIIb, with LVEF \< 40% referred to complete a cardiac rehabilitation program. All the patients benefit from a comprehensive cardiac rehabilitation program including educational program, therapeutical optimisation and exercise training for 20 sessions, 3 to 5 days a week. The group of patients randomized for additional EMS has 20 sessions of 1 hour electrical quadricipital myostimulation.

Interventions

DEVICELow electrical myostimulation

The group of patients randomized for additional EMS will have 20 sessions of 1 hour electrical quadricipital myostimulation.

Sponsors

Gulf Estuarine Research Society (GERS)
CollaboratorOTHER
Bourgogne Association of Cardiology
CollaboratorUNKNOWN
Ile-de-France Association of Cardiology
CollaboratorUNKNOWN
French Cardiology Society
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* age from 18 to 75 yo * stable Chronic Heart Failure (CHF) under optimal treatment since at least 1 week * NYHA functional class II to IIIb * left ventricular ejection fraction \< 40% * cardiopulmonary exercise test feasible * whatever etiology of heart failure * age of heart failure ≥ 3 months. * have signed the consent document to participate in the study

Exclusion criteria

* previous treatment by functional electrical myo stimulation * recent acute heart failure or inotropic intravenous agents used (\< 10 days) * recent coronary angioplasty (\< 10 days) * cardiac surgery \< 1 month * valvular disease requiring surgical treatment * uncontrolled hypertension (≥ systolic 180 and/or diastolic 110 mmHg) * severe respiratory insufficiency (VEMS \< 1000 ml) * pregnancy * Automatic implantable defibrillator * pace-makers : cardiac stimulation dependence or not known * incapacity to achieve 6 min walk test and/or exercise testing * absolute contra-indication to exercise test and/or exercise training * myocarditis or pericarditis * uncontrolled ventricular arrhythmias * Obesity (BMI ≥ 35) * known and documented peripheral myopathy * participation to another study protocol * patient incapable of giving consent

Design outcomes

Primary

MeasureTime frameDescription
Peak VO2at inclusion (baseline) then after 4 to 7 weeks of cardiac rehabilitationThe primary outcome is the improvement of peak VO2 estimated by relative changes between before and at the end of the cardiac rehabilitation program.

Secondary

MeasureTime frameDescription
Changes on muscular strengthat inclusion then after 4 to 7 weeks of cardiac rehabilitationMeasure of weight that the patient can lift 3 times but not four with quadriceps.
Changes on sub maximal parametersat inclusion then after 4 to 7 weeks of cardiac rehabilitationMeasure of ventilatory threshold and walk test of 6 min.
Modifications of quality of lifeat inclusion then after 4 to 7 weeks of cardiac rehabilitationMinnesota questionnaire completed by the patient

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026